EHC - Encompass Health Corporation

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 6.30B
Enterprise value 9.19B
Trailing P/E 22.45
Forward P/E 21.05
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.42
Price/book (mrq)4.55
Enterprise value/revenue 2.07
Enterprise value/EBITDA 10.11

Trading information

Stock price history

Beta (5Y monthly) 0.96
52-week change 338.69%
S&P500 52-week change 310.08%
52-week high 366.44
52-week low 342.19
50-day moving average 361.33
200-day moving average 356.62

Share statistics

Avg vol (3-month) 3747.95k
Avg vol (10-day) 3516.64k
Shares outstanding 5100.24M
Implied shares outstanding 6N/A
Float 898.01M
% held by insiders 11.79%
% held by institutions 199.72%
Shares short (14 May 2023) 42.33M
Short ratio (14 May 2023) 43.01
Short % of float (14 May 2023) 42.66%
Short % of shares outstanding (14 May 2023) 42.33%
Shares short (prior month 13 Apr 2023) 42.14M

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 40.95%
Trailing annual dividend rate 30.73
Trailing annual dividend yield 31.16%
5-year average dividend yield 41.60
Payout ratio 426.07%
Dividend date 316 July 2023
Ex-dividend date 429 June 2023
Last split factor 21257:1000
Last split date 330 June 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 6.09%
Operating margin (ttm)14.75%

Management effectiveness

Return on assets (ttm)6.46%
Return on equity (ttm)17.00%

Income statement

Revenue (ttm)4.45B
Revenue per share (ttm)44.83
Quarterly revenue growth (yoy)9.50%
Gross profit (ttm)1.75B
Net income avi to common (ttm)278.9M
Diluted EPS (ttm)2.80
Quarterly earnings growth (yoy)0.20%

Balance sheet

Total cash (mrq)85M
Total cash per share (mrq)0.85
Total debt (mrq)2.97B
Total debt/equity (mrq)151.49
Current ratio (mrq)1.29
Book value per share (mrq)13.81

Cash flow statement

Operating cash flow (ttm)714.8M
Levered free cash flow (ttm)70.31M